Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features

Affiliations

• ¹ Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. klughammer@genzentrum.lmu.de.
• ² Gene Center and Department of Biochemistry, Ludwig Maximilians Universität München, Munich, Germany. klughammer@genzentrum.lmu.de.
• ³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. daniel_abravanel@dfci.harvard.edu.
• ⁴ Harvard Medical School, Boston, MA, USA. daniel_abravanel@dfci.harvard.edu.
• ⁵ Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
• ⁶ Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
• ⁷ Baxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
• ⁸ Department of Media Arts and Sciences, McGovern Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ⁹ Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.
• ¹⁰ Faculty of Engineering, Gonda Brain Research Center and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan, Israel.
• ¹¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ¹² Broad Institute of Harvard and MIT, Cambridge, MA, USA.
• ¹³ Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Guiron University, Beersheba, Israel.
• ¹⁴ Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ¹⁵ Gene Center and Department of Biochemistry, Ludwig Maximilians Universität München, Munich, Germany.
• ¹⁶ School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
• ¹⁷ Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem, Israel.
• ¹⁸ Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
• ¹⁹ AstraZeneca R&D, Boston, MA, USA.
• ²⁰ Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA.
• ²¹ Department of Media Arts and Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ²² Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ²³ Department of Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ²⁴ Howard Hughes Medical Institute, Chevy Chase, MD, USA.
• ²⁵ Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ²⁶ K. Lisa Yang Center for Bionics, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ²⁷ Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
• ²⁸ Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
• ²⁹ Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ³⁰ Department of Physics, Harvard University, Cambridge, MA, USA.
• ³¹ Genentech, Inc., South San Francisco, CA, USA.
• ³² Harvard Medical School, Boston, MA, USA.
• ³³ Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. regev.aviv@gene.com.
• ³⁴ Genentech, Inc., South San Francisco, CA, USA. regev.aviv@gene.com.
• ³⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wagle.nikhil@gene.com.
• ³⁶ Harvard Medical School, Boston, MA, USA. wagle.nikhil@gene.com.
• ³⁷ Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA. wagle.nikhil@gene.com.
• ³⁸ Broad Institute of Harvard and MIT, Cambridge, MA, USA. wagle.nikhil@gene.com.
• ³⁹ Genentech, Inc., South San Francisco, CA, USA. wagle.nikhil@gene.com.